Biejiajian Pill Ameliorates Diabetes-Associated Atherosclerosis through Inhibition of the NLRP3 Inflammasome

<div>Dynamic body glucose and weight of mice. (a) Blood glucose of mice. (b) Bodyweight of mice. The blood glucose and bodyweight levels were assessed at 0, 4, 8, and 12 weeks of treatment. Values presented as mean (<i>n</i> = 10 per group).</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Biejiajian Pill Ameliorates Diabetes-Associated Atherosclerosis through Inhibition of the NLRP3 Inflammasome 